72 related articles for article (PubMed ID: 22843933)
1. The functional polymorphism of erythropoietin gene rs1617640 G>T is not associated with susceptibility and clinical outcome of early-stage breast cancer.
Szkandera J; Absenger G; Stotz M; Weissmueller M; Winder T; Langsenlehner T; Samonigg H; Renner W; Schippinger W; Gerger A
Anticancer Res; 2012 Aug; 32(8):3473-8. PubMed ID: 22843933
[TBL] [Abstract][Full Text] [Related]
2. Relation between renal dysfunction requiring renal replacement therapy and promoter polymorphism of the erythropoietin gene in cardiac surgery.
Popov AF; Schulz EG; Schmitto JD; Coskun KO; Tzvetkov MV; Kazmaier S; Zimmermann J; Schöndube FA; Quintel M; Hinz J
Artif Organs; 2010 Nov; 34(11):961-8. PubMed ID: 21092038
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin promoter polymorphism is associated with treatment efficacy and severe hematologic toxicity for platinum-based chemotherapy.
Zheng Y; Deng Z; Tang M; Cai P
Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):495-502. PubMed ID: 33461346
[No Abstract] [Full Text] [Related]
4.
Wang Y; Li Z; Zhang X; Lin A; Chen C; Zeng X; Pan Y; Mao C; Xie C; Huang D; Deng Y; Zhang X; Lu J; Wang X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):215. PubMed ID: 37796693
[TBL] [Abstract][Full Text] [Related]
5. Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome.
Ma W; Kantarjian H; Zhang K; Zhang X; Wang X; Chen C; Donahue AC; Zhang Z; Yeh CH; O'Brien S; Garcia-Manero G; Caporaso N; Landgren O; Albitar M
BMC Med Genet; 2010 Nov; 11():163. PubMed ID: 21078205
[TBL] [Abstract][Full Text] [Related]
6. Association between polymorphisms in erythropoietin gene and upper limit haematocrit levels among regular blood donors.
Khabour OF; Bani-Ahmad MA; Hammash NM
Transfus Clin Biol; 2012 Dec; 19(6):353-7. PubMed ID: 23142128
[TBL] [Abstract][Full Text] [Related]
7. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.
Azmy IA; Balasubramanian SP; Wilson AG; Stephenson TJ; Cox A; Brown NJ; Reed MW
Breast Cancer Res; 2004; 6(4):R395-400. PubMed ID: 15217507
[TBL] [Abstract][Full Text] [Related]
8. A novel polymorphism in the promoter region of ERBB4 is associated with breast and colorectal cancer risk.
Rokavec M; Justenhoven C; Schroth W; Istrate MA; Haas S; Fischer HP; Vollmert C; Illig T; Hamann U; Ko YD; Glavac D; Brauch H
Clin Cancer Res; 2007 Dec; 13(24):7506-14. PubMed ID: 18094435
[TBL] [Abstract][Full Text] [Related]
9. A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients.
Chiu CF; Wang HC; Wang CH; Wang CL; Lin CC; Shen CY; Chiang SY; Bau DT
Anticancer Res; 2008; 28(1A):267-70. PubMed ID: 18383855
[TBL] [Abstract][Full Text] [Related]
10. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin and erythropoietin receptor expression in human cancer.
Acs G; Acs P; Beckwith SM; Pitts RL; Clements E; Wong K; Verma A
Cancer Res; 2001 May; 61(9):3561-5. PubMed ID: 11325818
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of the DNA mismatch repair gene HMSH2 in breast cancer occurence and progression.
Poplawski T; Zadrozny M; Kolacinska A; Rykala J; Morawiec Z; Blasiak J
Breast Cancer Res Treat; 2005 Dec; 94(3):199-204. PubMed ID: 16252083
[TBL] [Abstract][Full Text] [Related]
13. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
[TBL] [Abstract][Full Text] [Related]
14. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility.
Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R
Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595
[TBL] [Abstract][Full Text] [Related]
15. The impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiation.
Rades D; Golke H; Schild SE; Kilic E
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):152-9. PubMed ID: 17967510
[TBL] [Abstract][Full Text] [Related]
16. Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications.
Tong Z; Yang Z; Patel S; Chen H; Gibbs D; Yang X; Hau VS; Kaminoh Y; Harmon J; Pearson E; Buehler J; Chen Y; Yu B; Tinkham NH; Zabriskie NA; Zeng J; Luo L; Sun JK; Prakash M; Hamam RN; Tonna S; Constantine R; Ronquillo CC; Sadda S; Avery RL; Brand JM; London N; Anduze AL; King GL; Bernstein PS; Watkins S; ; Jorde LB; Li DY; Aiello LP; Pollak MR; Zhang K
Proc Natl Acad Sci U S A; 2008 May; 105(19):6998-7003. PubMed ID: 18458324
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 -174G-->C polymorphism is associated with improved outcome in high-risk breast cancer.
DeMichele A; Martin AM; Mick R; Gor P; Wray L; Klein-Cabral M; Athanasiadis G; Colligan T; Stadtmauer E; Weber B
Cancer Res; 2003 Nov; 63(22):8051-6. PubMed ID: 14633738
[TBL] [Abstract][Full Text] [Related]
18. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
19. The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients.
Filip S; Vanásek J; Bláha M; Mericka P; Vávrová J; Podzimek K
Neoplasma; 1999; 46(3):166-72. PubMed ID: 10613592
[TBL] [Abstract][Full Text] [Related]
20. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
